Identification and Characterization of 4-Methylbenzyl 4-[(Pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an Orally Bioavailable, Brain Penetrant NR2B SelectiveN-Methyl-d-Aspartate Receptor Antagonist
- 24 January 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (4) , 807-819
- https://doi.org/10.1021/jm060983w
Abstract
The discovery of a novel series of NR2B subtype selective N-methyl-d-aspartate (NMDA) antagonists is reported. Initial optimization of a high-throughput screening lead afforded an aminopyridine derivative 13 with significant NR2B antagonist potency but limited selectivity over hERG-channel and other off-target activities. Further structure−activity studies on the aminoheterocycle moiety and optimization of the carbamate led to the highly potent 2-aminopyrimidine derivative 20j with a significantly improved off-target activity profile and oral bioavailability in multiple species coupled with good brain penetration. Compound 20j demonstrated efficacy in in vivo rodent models of antinociception, allodynia, and Parkinson's disease.Keywords
This publication has 24 references indexed in Scilit:
- NMDA Antagonists and Neuropathic Pain - Multiple Drug Targets and Multiple UsesCurrent Pharmaceutical Design, 2005
- Orally Efficacious NR2B-Selective NMDA Receptor AntagonistsBioorganic & Medicinal Chemistry Letters, 2003
- NMDA receptor subunits: diversity, development and diseaseCurrent Opinion in Neurobiology, 2001
- A neural pathway for itchNature Neuroscience, 2001
- Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal hornNeuropharmacology, 1999
- Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and agingProgress in Neurobiology, 1998
- Glutamate in CNS disorders as a target for drug development: an updateDrug News & Perspectives, 1998
- A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromesPublished by Wolters Kluwer Health ,1997
- 4-Substituted-3-phenylquinolin-2(1H)-ones: Acidic and Nonacidic Glycine SiteN-Methyl-d-aspartate Antagonists withinVivoActivityJournal of Medicinal Chemistry, 1997
- (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate ResponsesJournal of Medicinal Chemistry, 1995